WASHINGTON -- Hundreds of clinics pushing unproven stem cell procedures caught a big break from the U.S. government in 2017: They would have three years to show that their questionable treatments were safe and worked before regulators started cracking down.
But when the Food and Drug Administration's grace period expired in late May extended six months due to the pandemic the consequences became clear: Hundreds more clinics were selling the unapproved treatments for arthritis, Alzheimers, COVID-19 and many other conditions.
It backfired, says Leigh Turner, a bioethicist at the University of California, Irvine. The scale of the problem is vastly larger for FDA today than it was at the start.
The continuing spread of for-profit clinics promoting stem cells and other so-called regenerative therapies including concentrated blood products illustrates how quickly experimental medicine can outpace government oversight. No clinic has yet won FDA approval for any stem cell offering and regulators now confront an enormous, uncooperative industry that contends it shouldn't be subject to regulation.
Although emerging research suggests stem cells could someday have broad use for a number of medical conditions, experts say they should not be used outside of well-controlled studies or a handful of established uses. For instance, stem cells collected from blood or bone marrow have long been used to treat leukemia and other blood diseases.
Many clinics use so-called adult stem cells collected from tissue like fat or bone marrow not the more versatile but controversial stem cells from embryos used in research.
Turner and other experts have tracked the growth of the clinics for nearly a decade. Clinics charge between $2,000 to $25,000 for adult stem cell injections and other infusions which they advertise for an assortment of diseases, including diabetes, autism, cancer, multiple sclerosis and vision problems. Some clinics use stem cells derived from fat, harvested via liposuction then reinjected into patients, aiming to repair joints or fight disease. Others use bone marrow or blood taken from umbilical cords after birth.
There is no government tally of how many clinics operate in the U.S. But Turner counted more than 1,200 of them in 2019, up from the 570 clinics he and a co-author identified in 2016. Hes working on an update but says the number has consistently grown.
The FDA has repeatedly warned Americans to steer clear of unapproved and unproven stem cell therapies, which have occasionally caused blindness, bacterial infections and tumors. During FDA's three-plus years of enforcement discretion, the agency sent formal warning letters to more than a dozen businesses performing the riskiest procedures. Regulators also prevailed in a Florida court case to shutdown a major clinic offering unproven treatments. Another case against a similar prominent company is pending in California.
Its time to actually get the data we need, to assess clinics' stem cell procedures, FDA's Dr. Peter Marks said at an industry conference in June. He pointed to a multiyear effort by FDA to help clinics through the review process.
Many stem cell doctors continue to argue that their in-office procedures are outside FDAs purview. But FDA has concluded that processing stem cells and giving them to patients with serious diseases amounts to creating a new drug, which the agency regulates.
The FDA hasnt disclosed how many clinics sought approval since 2017, but public comments suggest it was troublingly low.
We have been very disappointed in the number of clinics that have come in, FDAs Dr. Wilson Bryan said at the same conference.
Bryan, who directs FDA's cell therapies division, added that he is extremely concerned by how many stem cell and related offerings remain available.
Tracking injuries from the procedures is difficult. Drugmakers and hospitals are required to report drug-related complications to the FDA, but no such requirements exist for individual doctors. And patients often don't know where to report problems.
David Stringham of Provo, Utah, says undergoing a procedure for joint pain at a local clinic was the worst decision of my life.
In 2018, Stringham was looking for an alternative to surgery for chronic pain in his right shoulder and elbows after years of weightlifting. He paid $2,400 for injections of so-called platelet-rich plasma at a clinic. It doesn't involve stem cells but the procedure is similar: doctors take a blood sample, process it to concentrate the platelets and then reinject them into the patient's problem areas in an attempt to speed healing.
The procedure went smoothly, but within hours Stringham was wracked by pain in his back, shoulder and arms.
It was a crazy amount of pain and I kept calling them saying something is not right," said the 51-year-old. And to this day Im not right."
The clinic gave Stringham medication for the pain and told him to be patient. But things didn't improve, even after months of physical therapy. Since then, a neurologist has told Stringham he probably suffered nerve damage at the places where he was injected.
His case was included in a Pew Charitable Trusts review of 360 reported injuries from stem cell and other regenerative procedures between 2004 and 2020. Nearly all the reports came from medical journals, government publications, social media or news reports. Just five came from FDAs database for medical injuries.
There are a lot of holes in the safety system, said Liz Richardson of Pew, who led the project.
The FDA didn't clearly assert its authority over such clinics until 2017. The next year, it began sending form letters to some 400 clinics, warning that they may be violating FDA rules. But the names of the clinics havent been publicized, and such warnings are often ignored.
Traditional medical researchers welcome the FDA actions but say its impossible to gauge their effect.
The business model is this: We can keep offering these products until things get serious with the FDA and then we can just take down our website', said Laertis Ikonomou, a stem cell researcher at the University of Buffalo who also heads a task force on the topic for the International Society for Cell and Gene Therapy.
He and other specialists say the clinics have damaged the reputation of legitimate stem cell research while also siphoning off patients who might otherwise enroll in studies.
Lawyers representing stem cell clinics say they have no choice but to resist FDA regulation.
FDA is pushing them into this drug development pathway, which nobody is adopting because it requires a million dollars worth of toxicology and animal studies just to show something is safe for human use, said Marc Scheineson, a former FDA attorney.
For now, people on both sides are waiting to see what FDA does.
We shouldnt feel too confident that the FDA has this wrapped up said Turner, the bioethicist. They really have invested some resources and they are trying to do something here but I think theyre just outmatched and overwhelmed.
Follow Matthew Perrone on Twitter: @APFDAwriter
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institutes Department of Science Education. The AP is solely responsible for all content.
See the original post here:
US stem cell clinics boomed while FDA paused crackdown ...
- The Stem Cell Debate: Is it Over? - University of Utah - November 24th, 2022
- Stem Cells in Use - University of Utah - November 6th, 2022
- Genes and Addiction - University of Utah - November 6th, 2022
- The History of Cloning - University of Utah - October 29th, 2022
- Brain-Like Organoids Grown in a Dish Provide Window into Autism - University of Utah Health Care - October 13th, 2022
- Brain Dissections: Neuroanatomy Video Lab - University of Utah - October 4th, 2022
- Calendar of events, awards and opportunities - ASBMB Today - August 22nd, 2022
- This Man Set the Record for Wearing a Brain-Computer Interface - WIRED - August 22nd, 2022
- STEMTECH CORPORATION Partners with VERB in Launching Interactive Video and Livestreaming Sales Enablement Apps to Strengthen Direct Sales Channel -... - July 27th, 2022
- Cloning and Stem Cells | Biological Principles - July 3rd, 2022
- Effect of tensile frequency on osteogenic differentiation | IJGM - Dove Medical Press - July 3rd, 2022
- The White Rim - Around Again - Cycling West - Cycling Utah - June 22nd, 2022
- Efficacy and Safety of Sintilimab in Combination with Concurrent Chemo | CMAR - Dove Medical Press - June 22nd, 2022
- Sen. Orrin Hatch's legacy tracks the GOP's evolution on health - NPR - May 2nd, 2022
- Stem Cell Quick Reference - University of Utah - October 28th, 2021
- Fasting boosts stem cells regenerative capacity | MIT ... - October 5th, 2021
- Learn how to remove unwanted fat with procedures beyond liposuction - ABC 4 - July 21st, 2021
- A $50,000 Helmet Can Read User's Mind. And It's Ready - NDTV - June 23rd, 2021
- Is the Tooth Fairy Real? the Origin Story to the Tooth Fairy, and Why It Is a Story Commonly Told Today - Digital Journal - June 23rd, 2021
- Childrens book, Olivias Tower: The Building Power of Cells - ABC 4 - October 13th, 2020
- New Stem Cell Injury Lawsuit Filed StemVive & Utah Cord Bank - June 15th, 2020
- Tolero Pharmaceuticals Announces Expansion of the Zella 102 Study in Patients with Intermediate and High-Risk Myelodysplastic Syndromes (MDS) -... - May 15th, 2020
- Surplus antioxidants are pathogenic for hearts and skeletal muscle - The Mix - May 15th, 2020
- On the Road to 3-D Printed Organs - The Scientist - March 2nd, 2020
- These Vaginas Evolved to Fight the Penis, Not Accommodate It - VICE - January 5th, 2020
- 5 Innovations From the Science of Senses Now. Powered by - Now. Powered by Northrop Grumman. - December 8th, 2019
- Brainstorm Cell Therapeutics Inc. (BCLI) and PolarityTE Inc. (NASDAQ:PTE) Contrasting side by side - The Broch Herald - December 8th, 2019
- Merus N.V. (MRUS) and PolarityTE Inc. (NASDAQ:PTE) Contrasting side by side - The Broch Herald - November 29th, 2019
- Intermountain to open new center for pediatric precision medicine - Healthcare IT News - November 29th, 2019
- Orthopedic Stem Cell Therapy in Utah for Painful Joints - September 7th, 2019
- Umbilical Cord Stem Cell Review: StemVive from Utah Cord ... - April 27th, 2019
- Mutation Generation & Detection HSC Cores: Home - March 10th, 2019
- Utah Stem Cells - Salt Lake City, UT - Yelp - January 4th, 2019
- Stem Cells for Hair in Park City, Utah Docere Medical - December 9th, 2018
- PRP vs Stem Cell Injections | Southwest Spine and Pain Center - September 24th, 2018
- Stem Cell Joint Regeneration | Utah Stem Cells - July 26th, 2018
- Transgenic Gene-Targeting Mouse Facility HSC Cores: Home - July 8th, 2018
- About Us | Utah Stem Cells - June 22nd, 2018
- Fasting for 24 hours regenerates stem cells, study finds ... - June 18th, 2018
- Adult Stem Cell Therapy in Utah Docere Clinics - October 1st, 2017
- Utah Stem Cells - Cottonwood Heights, UT | Groupon - September 26th, 2017
- COLUMN: Let's make biological warfare a crime - Journal Gazette and Times-Courier - September 2nd, 2017
- FDA Cracks Down On Stem-Cell Clinics Selling Unapproved Treatments - Utah Public Radio - August 30th, 2017
- Utah family sets up campground in Rexburg to fight cancer - Rexburg Standard Journal - August 25th, 2017
- Scientists Discover New Hair Growth Technique Using Stem Cells - TrendinTech - August 18th, 2017
- Stem cell researchers discover promising lead in quest for hair regrowth - PhillyVoice.com - August 18th, 2017
- UCLA scientists identify a new way to activate stem cells to make hair grow - UCLA Newsroom - August 18th, 2017
- Adult Stem Cells' Role in Disease Management and Anti-Aging - August 12th, 2017
- Fast facts about cloning - WPSD Local 6 - August 12th, 2017
- Reinventing tissue regeneration, one layer at a time - MedCity News - August 12th, 2017
- Q Therapeutics Expands Board of Directors With Appointment of Dr. Tom Parks as Independent Member - Marketwired (press release) - August 12th, 2017
- Stem Cell Therapy for Knees- Advanced Techniques - December 6th, 2016
- Utah Stem Cells - Sports Medicine - 7430 Creek Rd, Sandy ... - December 3rd, 2016
- Biochemistry - | University of Utah - November 26th, 2016
- medicine.utah.edu - University of Utah School of Medicine - November 23rd, 2016
- Home - Department of Chemistry - The University of Utah - November 23rd, 2016
- Stem Cell Quick Reference - Learn Genetics - November 18th, 2016
- Amniotic Stem Cell Therapy in Salt Lake City, Park City Utah - August 22nd, 2016
- Curriculum Index - University of Utah - October 19th, 2015
- Actionbioscience | Stem Cells for Cell-Based Therapies - May 4th, 2015
- Heart Stem Cell Therapy | University of Utah Health Care - April 18th, 2015
- Hyperbaric oxygen therapy and its benefits on wound treatment - March 11th, 2015
- Stem Cell Collection - University of Utah Internal ... - March 10th, 2015
- What are stem cells? - Craig A. Kohn | TED-Ed - December 12th, 2014
- What Are Stem Cells? - CSA - November 15th, 2014
- Tennis: Rafael Nadal to receive stem cell treatment for ... - November 12th, 2014
- Stem Cells in India | Stem Cell Therapy in India | Quality ... - October 16th, 2014
- Teacher Guide: Stem Cell Multimedia Project ACTIVITY OVERVIEW - September 27th, 2014
- Utah Cord Bank | 1-877-UCB-STEM | - September 27th, 2014
- Utah Stem Cell Therapy | Stem Cell Treatments - August 22nd, 2014
- Heart Stem Cell Therapy - - - University of Utah Health ... - August 22nd, 2014